Cardiovascular health in pediatric patients with X-linked hypophosphatemia under two years of burosumab therapy
IntroductionX-linked hypophosphatemia (XLH) is caused by an inactivating mutation in the phosphate-regulating endopeptidase X-linked (PHEX) gene whose defective product fails to control phosphatonin fibroblast growth factor 23 (FGF23) serum levels. Although elevated FGF23 levels have been linked wit...
Zapisane w:
| Główni autorzy: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Frontiers Media S.A.
2024-05-01
|
| Seria: | Frontiers in Endocrinology |
| Hasła przedmiotowe: | |
| Dostęp online: | https://www.frontiersin.org/articles/10.3389/fendo.2024.1400273/full |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|